scholarly article | Q13442814 |
P2093 | author name string | Ross L Cagan | |
Benjamin D Levine | |||
P2860 | cites work | FGF-10 is a chemotactic factor for distal epithelial buds during lung development | Q24314375 |
Dual origin of tissue-specific progenitor cells in Drosophila tracheal remodeling | Q24567729 | ||
Endoreplication cell cycles: more for less | Q28188424 | ||
Comprehensive genomic characterization of squamous cell lung cancers | Q28274701 | ||
Mutational landscape and significance across 12 major cancer types | Q28300353 | ||
Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis | Q28592724 | ||
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt | Q29547767 | ||
Drug combination studies and their synergy quantification using the Chou-Talalay method | Q29617422 | ||
Matrix metalloproteinases: regulators of the tumor microenvironment | Q29619858 | ||
FGF is an essential mitogen and chemoattractant for the air sacs of the drosophila tracheal system | Q34145948 | ||
Increased RhoA prenylation in the loechrig (loe) mutant leads to progressive neurodegeneration | Q34412406 | ||
Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. | Q34443426 | ||
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis | Q34605246 | ||
Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. | Q35823933 | ||
The Ras-Erk-ETS-Signaling Pathway Is a Drug Target for Longevity | Q35898911 | ||
Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice | Q36035654 | ||
Mechanisms of steroid-triggered programmed cell death in Drosophila | Q36083635 | ||
Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets | Q36856455 | ||
Atorvastatin overcomes gefitinib resistance in KRAS mutant human non-small cell lung carcinoma cells | Q37211974 | ||
Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibition | Q37331610 | ||
Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors | Q37355543 | ||
Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition. | Q37396608 | ||
Morphogenesis of epithelial tubes: Insights into tube formation, elongation, and elaboration | Q37602752 | ||
Molecular aspects of respiratory and vascular tube development. | Q37733862 | ||
A Drosophila asthma model - what the fly tells us about inflammatory diseases of the lung | Q37962858 | ||
MEK inhibition in non-small cell lung cancer | Q38254501 | ||
Statin induces inhibition of triple negative breast cancer (TNBC) cells via PI3K pathway | Q39105805 | ||
Statins exhibit anticancer effects through modifications of the pAkt signaling pathway | Q39459037 | ||
Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells | Q39799421 | ||
In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models. | Q39830937 | ||
Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells | Q39835633 | ||
Fluvastatin prevents oxidized low-density lipoprotein-induced injury of renal tubular epithelial cells by inhibiting the phosphatidylinositol 3-kinase/Akt-signaling pathway | Q40250359 | ||
Ras Isoprenylation and pAkt Inhibition by Zoledronic Acid and Fluvastatin Enhances Paclitaxel Activity in T24 Bladder Cancer Cells | Q41815934 | ||
Isoprenoids control germ cell migration downstream of HMGCoA reductase | Q44762411 | ||
Tracheal branch repopulation precedes induction of the Drosophila dorsal air sac primordium | Q44776302 | ||
Distinct roles for two receptor tyrosine kinases in epithelial branching morphogenesis in Drosophila | Q46834686 | ||
Specification of differentiated adult progenitors via inhibition of endocycle entry in the Drosophila trachea. | Q52783292 | ||
A cellular process that includes asymmetric cytokinesis remodels the dorsal tracheal branches in Drosophila larvae. | Q52803044 | ||
Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells | Q79464851 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lung cancer | Q47912 |
Drosophila | Q312154 | ||
P304 | page(s) | 1477-1487 | |
P577 | publication date | 2016-01-27 | |
P1433 | published in | Cell Reports | Q5058165 |
P1476 | title | Drosophila Lung Cancer Models Identify Trametinib plus Statin as Candidate Therapeutic | |
P478 | volume | 14 |
Q64076685 | : A Model Organism to Study Cancer |
Q90103147 | A Drosophila Based Cancer Drug Discovery Framework |
Q58700499 | A model of cigarette smoke induced COPD identifies Nrf2 signaling as an expedient target for intervention |
Q48235069 | A pharmacological screen for compounds that rescue the developmental lethality of a Drosophila ATM mutant. |
Q90389012 | A triple drug combination targeting components of the nutrient-sensing network maximizes longevity |
Q55335270 | Blockage of the mevalonate pathway overcomes the apoptotic resistance to MEK inhibitors with suppressing the activation of Akt in cancer cells. |
Q90375152 | Cytoneme-mediated signaling essential for tumorigenesis |
Q58760969 | Dme-Hsa Disease Database (DHDD): Conserved Human Disease-Related miRNA and Their Targeting Genes in |
Q90103101 | Drosophila Model in Cancer: An Introduction |
Q90103137 | Drosophila as a Model for Tumor-Induced Organ Wasting |
Q39039978 | Drug Discovery in Fish, Flies, and Worms |
Q49958316 | EGFR-PI3K-PDK1 pathway regulates YAP signaling in hepatocellular carcinoma: the mechanism and its implications in targeted therapy. |
Q37676070 | Epidermal Growth Factor Pathway Signaling in Drosophila Embryogenesis: Tools for Understanding Cancer. |
Q64040190 | From gene to treatment: supporting rare disease translational research through model systems |
Q89735579 | Inhibition of ISG15 Enhances the Anti-Cancer Effect of Trametinib in Colon Cancer Cells |
Q90702676 | Inhibitory effects of viral infection on cancer development |
Q64086483 | Integrated computational and Drosophila cancer model platform captures previously unappreciated chemicals perturbing a kinase network |
Q92128564 | MEK nuclear localization promotes YAP stability via sequestering β-TrCP in KRAS mutant cancer cells |
Q91823874 | Modeling Cancer with Flies and Fish |
Q52310247 | Modelling Cooperative Tumorigenesis in Drosophila. |
Q47724734 | Non-mammalian models of multiple endocrine neoplasia type 2. |
Q48208216 | Reversal of hyperactive Wnt signaling-dependent adipocyte defects by peptide boronic acids. |
Q94569373 | Sequential Ras/MAPK and PI3K/AKT/mTOR pathways recruitment drives basal extrusion in the prostate-like gland of Drosophila |
Q93062858 | Spz/Toll-6 signal guides organotropic metastasis in Drosophila |
Q90293432 | The Air Sac Primordium of Drosophila: A Model for Invasive Development |
Q37203727 | The Lantibiotic NAI-107 Efficiently Rescues Drosophila melanogaster from Infection with Methicillin-Resistant Staphylococcus aureus USA300. |
Q28079088 | The interplay between obesity and cancer: a fly view |
Search more.